Verve Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Verve Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 506% to $11,758,000. Profit margin reached -1702%. Total operating expenses were $234,882,000.
Profit Margin
| 2019 | 0 | -19.01M | |
|---|---|---|---|
| 2020 | 0 | -45.54M | |
| 2021 | 0 | -118.63M | |
| 2022 | 1.94M | -157.38M | -8108.55% |
| 2023 | 11.75M | -200.06M | -1701.55% |
VERV Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 11.75M | 1.94M | 0 | 0 | 0 |
Cost of revenue | 5.45M | 6.71M | 3.37M | 1.32M | 106K |
Gross profit | 6.30M | -4.77M | -3.37M | -1.32M | -106K |
Operating exp. | |||||
Research and development | 184.94M | 130.09M | 68.20M | 35.37M | 11.14M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 234.88M | 167.62M | 87.06M | 40.62M | 13.64M |
Operating income | -223.12M | -165.68M | -87.06M | -40.62M | -13.64M |
Other income (expenses), net | 23.33M | 8.35M | -33.24M | -5.07M | -5.65M |
Income before tax | -199.79M | -157.33M | -120.31M | -45.70M | -19.29M |
Income tax expense | 275K | 53K | -1.67M | -162K | -278K |
Net income | -200.06M | -157.38M | -118.63M | -45.54M | -19.01M |
Earnings per share | |||||
Basic EPS | -3.12 | -2.91 | -2.45 | -0.94 | -0.39 |
Diluted EPS | -3.12 | -2.91 | -2.45 | -0.94 | -0.39 |
| Data source | Data source | Data source |